Medscape would like to know how you manage migraine when calcitonin gene-related peptide (CGRP)-targeted therapy falls short, which emerging targets interest you most, and how these options might fit into your clinical practice.CreditsLead image: iStock/Getty ImagesMedscape Reader Polls © 2026 WebMD, LLCCite this: Medscape Poll: New Targets in Migraine: Where Do They Fit in Your Practice? - Medscape - October 09, 2026. Comments Commenting is limited to medical professionals. To comment please . Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.TOP PICKS FOR YOU
New Targets in Migraine: Where Do They Fit in Your Practice?
Full Article
Original Source
Read the full article at Medscape →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.